|
ACHIEVEMENTS IN STANDARDIZATION
In recognizing the special infinite
responsibilities of medicines which have
a direct effect on human life, DELTA
was Syria's first pharmaceutical company
to be registered as a quality assured
firm through the achievement of ISO 9002
certificate no. 01503-99 on 15/nov/1999
by Det Norske Veritas (DNV).
Also DELTA achieved ISO 9001, ISO 14001,
and OHSAS 18001.
DELTA plants are approved and commit to
GMP standards in keeping with WHO
guidelines and fulfill all legal and
statutory requirements for manufacturing
drugs.
OUR VISION, OUR GOALS
DELTA Medicaments will remain the market
leader to raise pharmaceutical industry
levels in Syria, and to improve
consumers trust and loyalty for the
local products.
We are working hard to guarantee top
quality products in order to enter the
global market, our products reached
several countries of the world, and we
are looking forward to have a new market
share in new countries.
By now our products are marketed and
appreciated in a lot of countries.
Marketing strategy of our drugs is based
on scientific promotion through local
distributors.
During the last years, the company has
consistently invested in the improvement
of equipments and production processes.
PRODUCTS
To meet the increasing demand of DELTA's
products from the domestic and
international markets; DELTA 's range of
high quality products commits to the
international standards; Very high
quality scales, Excellent packaging,
competitive prices, and timely
deliveries, which has insured repeated
orders.
DELTA produces more than 115 different
products of all pharmaceutical forms
such as: Syrups, tablets and coated
tablets, capsules, oral drops,
solutions, ointments, Eye , ear and nose
drops, oral powders, nasal sprays,
vials, sashes, and oral suspension.
Sources of raw materials are from
international trustful companies such as
ROCHE– AVENTIS–UP JOHN – MEDEX –
MERCK … etc.
Perseverance and utmost confidence in
the quality of its products made DELTA
slowly but surely establish a name in
foreign markets. |